NASDAQ$VTRS
Viatris Inc · Q4 2024 earnings
Q4 2024 earnings · · Before market open · Investor relations
Briefing
Viatris reported a decline in Q4 2024 revenue and profitability, with efforts to stabilize operations and streamline costs.
Viatris posted Q4 2024 revenue of $3.52 billion, reflecting an 8% decline year-over-year. The company reported a GAAP net loss of $516.5 million and adjusted EPS of $0.54. While the Greater China segment showed positive growth, other geographic regions and product categories experienced declines.
- Total revenue for Q4 2024 was $3.52 billion, down 8% year-over-year.
- GAAP net loss of $516.5 million, with an adjusted EPS of $0.54.
- Brands revenue declined 10% year-over-year to $2.17 billion.
- Free cash flow of $342.3 million, down 15% compared to Q4 2023.
Headline financials
Revenue & EPS history
Viatris · Revenue · Quarterly
$3.53B
Revenue by segment
Viatris · $2.44B total across 1 segment · Q2 2023
- Brands$2.44B-1.5%100.0%
Forward guidance
Viatris expects 2025 revenue between $13.5 billion and $14 billion, with a focus on capital returns and operational efficiency.
Tailwinds
- Revenue guidance of $13.5 billion to $14 billion for 2025.
- Anticipates $450 million to $550 million in new product revenues.
- Plans for $500 million to $650 million in share repurchases.
- Continued focus on reducing leverage and improving financial flexibility.
- Potential pipeline milestones for late-stage drug candidates.
Headwinds
- Indore facility regulatory issues expected to impact 2025 revenue by $500 million.
- Adjusted EBITDA impact of $385 million due to regulatory actions.
- Ongoing net losses despite cost-cutting efforts.
- Declines in key geographic segments, except for Greater China.
- Increased competitive pressures affecting branded product sales.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2024
+0.3%
Avg return
Earnings day
+0.5%
Avg return
5 days after
-1.2%
Avg return
30 days after
52%
26 / 50 earnings
Positive
+14.4%
Q3 2022
Best reaction
-30.2%
Q4 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +11.3% | +9.1% | +3.0% | |
| Q4 2025 | -4.3% | -7.4% | -18.8% | |
| Q3 2025 | -6.5% | +4.2% | +1.7% | |
| Q1 2025 | +5.8% | +2.2% | +1.3% | |
| Q4 2024 | -15.2% | -16.6% | -22.8% | |
| Q3 2024 | +11.6% | +11.4% | +9.6% | |
| Q2 2024 | +3.7% | +1.8% | -0.8% | |
| Q1 2024 | -5.5% | -5.7% | -11.3% | |
| Q4 2023 | -6.5% | -6.6% | -9.8% | |
| Q3 2023 | +0.1% | -0.1% | +6.0% | |
| Q2 2023 | +5.3% | +7.2% | -4.4% | |
| Q1 2023 | +5.0% | +0.0% | +4.6% | |
| Q4 2022 | -1.0% | -3.3% | -17.2% | |
| Q3 2022 | +14.4% | +17.9% | +12.4% | |
| Q2 2022 | +7.5% | +14.4% | -0.1% | |
| Q1 2022 | +5.1% | +11.4% | +19.2% | |
| Q4 2021 | -30.2% | -29.8% | -24.4% | |
| Q3 2021 | +6.1% | +2.8% | -9.5% | |
| Q2 2021 | +6.0% | +4.9% | +2.1% | |
| Q1 2021 | +7.5% | +13.6% | +9.7% | |
| Q4 2018 | -3.8% | -6.3% | -5.9% | |
| Q4 2020 | -3.8% | -18.5% | -23.1% | |
| Q3 2020 | +3.8% | +2.8% | +17.0% | |
| Q2 2020 | -3.0% | -2.3% | -7.9% | |
| Q1 2020 | +4.2% | -3.7% | +4.8% | |
| Q4 2019 | +4.2% | -3.7% | +4.8% | |
| Q3 2019 | +2.5% | -2.0% | +1.6% | |
| Q2 2019 | +2.1% | +3.4% | +9.1% | |
| Q1 2019 | +0.5% | -3.2% | -3.8% | |
| Q3 2018 | -0.3% | -1.6% | -14.8% | |
| Q2 2018 | +0.8% | -1.0% | -0.3% | |
| Q1 2018 | -4.0% | -0.9% | -4.4% | |
| Q4 2017 | +1.9% | +4.7% | +8.7% | |
| Q3 2017 | +5.0% | +22.5% | +24.3% | |
| Q2 2017 | -0.6% | -0.7% | -0.8% | |
| Q1 2017 | -3.4% | -4.1% | -7.4% | |
| Q4 2016 | +4.6% | +6.0% | -1.9% | |
| Q3 2016 | -5.2% | -5.6% | -7.5% | |
| Q2 2016 | +1.0% | +1.5% | +9.3% | |
| Q1 2016 | -1.4% | — | — | |
| Q4 2015 | -2.2% | — | — | |
| Q3 2015 | -1.5% | — | — | |
| Q2 2015 | -1.7% | — | — | |
| Q1 2015 | -3.7% | — | — | |
| Q4 2014 | -2.3% | — | — | |
| Q3 2014 | -1.7% | — | — | |
| Q2 2014 | +0.1% | — | — | |
| Q1 2014 | +0.0% | — | — | |
| Q4 2013 | +1.4% | — | — | |
| Q3 2013 | -0.4% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro